MEDNAX Profile

45.01
USD 0.8  1.75%
25%
72%

Acquisition by Donna Shalala of 1625 shares of MEDNAX subject to Rule 16b-3

MEDNAX insider trading alert for grant of common stock by Donna Shalala, the corporate stakeholder, on June 18, 2018. This event was filed by Mednax Inc with SEC on 2012-06-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

MEDNAX Summary

MEDNAX (MD) is traded on New York Stock Exchange in USA. It is located in FLORIDA, U.S.A and employs 11,825 people. MEDNAX is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with market capitalization of 4.21 B. MEDNAX is active under Healthcare sector as part of Healthcare Services industry. This company has 93.46 M outstanding shares of which 2.65 M shares are now sold short in the market by investors with about 3.3 days to cover all shorted shares. Mednax reports about 51.78 M in cash with 326.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Check MEDNAX Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 45.01HorizonTargetOdds Above 45.01
6.53%30 days 45.01 93.25%
Based on normal probability distribution, the odds of MEDNAX to move above current price in 30 days from now is more than 93.0% (This MEDNAX probability density function shows the probability of MEDNAX Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Price T Rowe Associates IncCommon Shares9.6 M532.1 M
Vanguard Group IncCommon Shares8 M445.6 M
View MEDNAX Diagnostics

Selected MEDNAX Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

MEDNAX Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
45 
Equity ratings for MEDNAX are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida. MEDNAX operates under Medical Care classification in USA and traded on New York Stock Exchange. It employs 11825 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
NameMEDNAX
CEO, DirectorRoger MedelView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Healthcare Services
InstrumentUSA Stock View All
RegionNorth America
LocationFLORIDA, U.S.A
Business Address1301 Concord Terrace
Foreign Associate  Mexico
ExchangeNew York Stock Exchange
CIK Number00893949.0
ISINUS58502B1061
CUSIP58502B106
SectorHealthcare
IndustryHealthcare Services
BenchmarkDOW
Websitewww.mednax.com
Contact Number954 384 0175
Related EntityPDX
CurrencyUSD - US Dollar

Current Sentiment - MD

MEDNAX Investor Sentiment
Larger part of Macroaxis users are now bullish on MEDNAX. What is your trading attitude regarding investing in MEDNAX? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Recommendations

MEDNAX Analyst Recommendations
Target PriceAdvice# of Analysts
68.5Hold8Odds
MEDNAX current and past analyst recommendations published by number of research institutions as well as average analyst consensus
MEDNAX Analyst Advice  

Earnings

MEDNAX Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82April 27, 2017
MEDNAX normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

MEDNAX Corporate Directors
Enrique Sosa Independent Director, Ph.D
Waldemar Carlo Independent Director
Paul Gabos Independent Director
Please see also Stocks Correlation. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.